WB
The startup specializes in molecular targeting and antibody drug development for oncology, autoimmunity, and inflammation. By focusing on precise therapeutic mechanisms, the company aims to deliver effective treatments that improve patient outcomes in these complex disease areas.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup specializes in molecular targeting and antibody drug development for oncology, autoimmunity, and inflammation. By focusing on precise therapeutic mechanisms, the company aims to deliver effective treatments that improve patient outcomes in these complex disease areas.